THE FORMATION OF CHRONIC COMPLICATIONS OF TYPE 1 DIABETES IN DEPENDENCE OF THE DISEASE FEATURES (literary review and own data)

Authors

  • Khyzhnyak О. O. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Tykhonova T. M. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Barabash N. Ye. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2014.4.10

Keywords:

type 1 diabetes mellitus, chronic complications

Abstract

In the review is present the literature data devoted to the peculiarities the flow of type 1 diabetes in adults (analyzed a number of studies), provides examples of our own observations. In view of inconsistency of existing points of view about the development and progression of chronic complications of the disease in the adult patient population is justified need for further study of this problem.

References

Diabetes Atlas, available at: http://www.idf.org/atlasmap/atlasmap.

Obesity: Global status report on noncommunicable diseases 2010, Geneva, 2011: 176 p.

Chernobrov AD. Endokrinologija 2014; 19(1):40.

Kuraeva TL, Shirjaeva TJu, Titovich EV, Prokof’ev SA. Problemy Jendokrinologii 2011; 1:19-25.

Saicrian KA. Study on the Role of Genes of Innate Immunity in Type 1 Diabetes, Stocholm, 2010: 69 p.

Bol’shova OV, Samson OJa, Muz’ VA, et al. Simejna Medycyna 2008; 1:23-28.

Pihoker C, Badaru A, Anderson A, et al. Diabetes Care 2013; 36(1):27-33.

Newhook LA, Penney S, Fiander J, Dowden J. BMC Res Notes 2012; 5:628-631.

Pan’kiv VI. Mizhnar Endokrynol Zhurn 2013; 1(55):95-104.

Dib SA. Arq Bras. Endocrinol Metab 2008;52(2):205-218.

Diabetes Care 2012; 35(1):S64-S71.

Budrejko OA. Endokrynologija 2010; 15(1):71-79.

Pozzilli P, Di Mario U. Diabetes Care 2001; 24(8):1460-1467.

Tuomi T, Groop LC, Zimmet PZ, et al. Diabetes 1993; 42(2):359-362.

David M, Nathan D. Diabetes Care 2014; 37(1):9-16.

Suncov JuI, Maslova OV, Dedov II. Probl Jendokrinologii 2010; 1:3-8.

Avakova KA. Optimizacija metodov sovremennoj insulinoterapii pri lechenii saharnogo diabeta 1 tipa, Moskva, 2009: 144 p.

Kravchun NA, Grinchenko TS, Dunaeva IP. Endokrynologija 2013; 18(1):37-43.

Hilliard ME, Wu YP, Rausch J, et al. J Adolesc Health 2013; 52(1):28-34.

Nalysnyc L, Hernandez-Medina M, Krishnarajah G. Diabetes Obes Metab 2010; 12:288-298.

Bondar’ IA, Maksimova EG, Shabel’nikova OJu. Sibirskij Med Zhurn 2011; 26(4):103-106.

Sun JK, Keenan HA, Cavallerano JD, et al. Diabetes Care 2011; 34:968-974.

Dedov II, Shestakova MV. Saharnyj diabet: diagnostika,lechenie, profilaktika, Moskva, 2011: 808 p.

Ghanchi, F. Diabetic Retinopathy Guidelines, London, 2012: 147 p.

Komarov AV. Kliniko-funkcional’nye harakteristiki organa zrenija pri saharnom diabete 1 tipa, Moskva, 2014: 133 p.

Demirel F, Tepe D, Kara Ö, Esen İ. J Clin Res Pediatr Endocrinol 2013; 5(3):145-149.

Bel’china JuB, Sokolova LK, Tron’ko MD. Medycyna Transportu Ukrai’ny 2013; 3:17-21.

Orchard TJ, Costacou T, Kretowski A, Nesto RW. Diabetes Care 2006; 29:2528-2538.

Strokov IA, Zaharov VV, Strokov KI. Nevrologija, Nejropsihiatrija, Psihosomatika 2012; 2:30-40.

Myhajlychenko T Je. Diabetychna encefalopatija: faktory ryzyku, mehanizmy formuvannja, diagnostyka, likuvannja, Harkiv, 2009: 37 p.

Pashkovs’ka NV, Pashkovs’kyj VM. Ukr Visn Psyhonevrologii’ 2012; 20(4):17-20.

Lyoo IK, Yoon S, Renshaw PF, et al. PLoS ONE 2013; 8(8):e71304.

Pashkovs’ka NV, Pashkovs’kyj VM. Mezhdunar Nevrol Zhurn 2011; 3(41)17-20.

Augustina MA, et al. Eur J Pharmacol 2004; 490:159-168.

Nathan DM, Cleary PA, Backlund JY, et al. N Engl J Med 2005; 353:2643-2653.

Saenko JaA, Kovalenko AV, Man’kovskij BN. Endokrynologija 2013; 18(1):50-53.

Chugunov PA, Semenova IV. Saharnyj Diabet 2008; 1:61-68.

Mishhenko TS, Perceva TG. Ukr Nevrol Zhurn 2008; 3(8):4-13.

Poncelet AN. Mezhdunar Nevrol Zhurn 2010; 5(35):81-86.

Martin CL. Diabetes Care 2006; 29:340-344.

Resnenko A. Vrach 2011; 8:27-30.

Levin OS. Consilium Medicum 2011; 11(9):70-76.

Kravchun NA. Racional’naja Farmakoterapija 2008; 2(7):14-19.

Tirikov IV. Diabeticheskaja polinejropatija (faktory riska, prognozirovanie razvitija, varianty klinicheskogo techenija), Irkutsk, 2012: 112 p.

Dyck JJB, Dyck PJ. Diabetic Neuropathy, Philadelphia, 1999: 264-267.

Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetes Care 2005; 28(4):956-962.

Feldman EL, Russell JW, Sullivan KA, Golovoy D. Curr Opin Neurol 1999; 12(5):553-563.

Vlasenko MV. Mizhnar Endokrynol Zhurn 2011; 7(39):44-49.

Dzjak LA, Zozulja OA. Mezhdunar Nevrol Zhurn 2008; 4(20), available at: www.mif-ua.com/archive/article/7170.

Al’bekova ZhS. Rasprostranennost’ diabeticheskoj polinejropatii u bol’nyh saharnym diabetom 1 tipa. Kliniko-jelektrofiziologicheskoe, geneticheskoe issledovanie, Moskva, 2011: 22 p.

Herman WH, Kennedy L. Diabetes Care 2005; 28:1480-1481.

Kalashnikov AI, Chobit’ko VG, Maksimova OV, Rodionova TI. Sarat Nauch-Med Zhurn 2012; 8(2):442-445.

Danilov LI, Jaroshevich NA. Saharnyj diabet i ego oslozhnenija: klinicheskie varianty diabeticheskoj nejropatii, Minsk, 2009: 67 p.

Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetes Care 2004; 27:1458-1486.

Casellini CM, Vinik AI. Endocrinol Pract 2007; 13(5):550-566.

Vinik AI, Ziegler D. Circulation 2007; 115:387-397.

Bril V, Buchanan RA. Diabetes Care 2006; 29:68-72.

Vinik A, Erbas T, Pfeifer MA, et al. Diabetes Mellitus, 6th ed, New York, 2003: 789-804.

Pop-Busui R, Herman WH, Feldman EL, et al. Curr Diab Rep 2010; 10:276-282.

Albers JW, Herman WH, Pop-Busui R, et al. Diabetes Care 2010; 33(5):1090-1096.

Trence DL. Clin Diab 2002; 20:103-104.

Gries FA, Cameron NE, Low PA.Textbook of Diabetic Neuropathy, Stuttgart, 2003: 394 p.

Tkach S. Avtonomna nejropatija u hvoryh na cukrovyj diabet 1 typu: faktory ryzyku, perebig, diagnostyka i likuvannja, Kyi’v, 2008: 41 p.

Downloads

Published

2014-12-08

How to Cite

Khyzhnyak О. O., Tykhonova, T. M., & Barabash, N. Y. (2014). THE FORMATION OF CHRONIC COMPLICATIONS OF TYPE 1 DIABETES IN DEPENDENCE OF THE DISEASE FEATURES (literary review and own data). Problems of Endocrine Pathology, 50(4), 83-94. https://doi.org/10.21856/j-PEP.2014.4.10

Similar Articles

You may also start an advanced similarity search for this article.